Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia
  1. Home
  2. Publications
  3. Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia

Targeting IGF2BP3 Enhances Anti-Leukemic Effects of Menin-MLL Inhibition in MLL-AF4 Leukemia

Authors:
  • TLTasha L. Lin
    Tasha L. Lin
  • ARAlexander J. Ritter
    Alexander J. Ritter
  • AJAmit K. Jaiswal
    Amit K. Jaiswal
  • JRJenna Reppas
    Jenna Reppas
  • TTTiffany M. Tran
    Tiffany M. Tran
  • ZNZachary T. Neeb
    Zachary T. Neeb
  • SKSol Katzman
    Sol Katzman
  • JSJeremy R. Sanford
    Jeremy R. Sanford
  • DRDinesh S. Rao
    Dinesh S. Rao

Open Access
Publisher website
Google Scholar
  • 2 November 2023
    • journal article
    • abstracts
    • Published by American Society of Hematology in Blood
    • Vol. 142  (Supplement) , 5692
    • DOI:10.1182/blood-2023-174813
Abstract
Disclosures. Rao:AbbVie, Inc: Consultancy, Speakers Bureau.
Keywords
  • LEUKEMIA DISCLOSURES
  • ENHANCES ANTI-LEUKEMIC
  • TARGETING
  • ANTI-LEUKEMIC EFFECTS
  • MENIN-MLL INHIBITION
  • SPEAKERS BUREAU
  • ENHANCES
  • LEUKEMIA
  • DISCLOSURES
  • CONSULTANCY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.